Edesa Biotech (EDSA) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free EDSA Stock Alerts $4.62 +0.09 (+1.99%) (As of 12:18 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Edesa Biotech Short Interest DataCurrent Short Volume16,100 sharesPrevious Short Volume15,200 sharesChange Vs. Previous Month+5.92%Dollar Volume Sold Short$71,532.30Short Interest Ratio / Days to Cover1.5Last Record DateApril 30, 2024Outstanding Shares3,220,000 sharesFloat Size2,330,000 sharesShort Percent of Float0.69%Today's Trading Volume31,513 sharesAverage Trading Volume11,237 sharesToday's Volume Vs. Average280% Short Selling Edesa Biotech ? Sign up to receive the latest short interest report for Edesa Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEDSA Short Interest Over TimeEDSA Days to Cover Over TimeEDSA Percentage of Float Shorted Over Time Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.Click here to sign up for our free report & newsletter Edesa Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202416,100 shares $71,532.30 +5.9%0.7%1.5 $4.44 4/15/202415,200 shares $62,624.00 -22.1%0.7%1.2 $4.12 3/31/202419,500 shares $81,738.15 +10.2%0.8%1.4 $4.19 3/15/202417,700 shares $77,703.00 +4.1%0.8%1.2 $4.39 2/29/202417,000 shares $77,860.00 +11.8%0.7%0.6 $4.58 2/15/202415,200 shares $85,880.00 -27.6%0.7%0.5 $5.65 Get the Latest News and Ratings for EDSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/202421,000 shares $93,450.00 +2,525.0%0.9%0.7 $4.45 1/15/2024800 shares $3,728.00 -93.4%0.0%0 $4.66 12/31/202312,100 shares $55,297.00 -61.7%0.5%0.1 $4.57 12/15/202331,600 shares $164,004.00 +1,404.8%1.4%0.3 $5.19 11/30/20232,100 shares $6,930.00 -91.0%0.1%0 $3.30 11/15/202323,200 shares $67,280.00 -21.6%1.1%0.3 $2.90 10/31/202329,600 shares $95,312.00 -50.3%1.4%0.4 $3.22 10/15/202359,500 shares $235,322.50 -80.2%2.8%0.8 $3.96 9/30/2023300,200 shares $1.33 million -4.9%N/A3.5 $4.42 9/15/2023315,500 shares $283,950.00 -0.9%N/A6.5 $0.90 8/31/2023318,200 shares $269,515.40 -49.7%N/A5.8 $0.85 8/15/2023632,100 shares $537,285.00 -1.4%N/A11.5 $0.85 7/31/2023641,300 shares $525,866.00 -0.1%N/A10.8 $0.82 7/15/2023641,700 shares $534,471.93 -3.2%N/A8.9 $0.83 6/30/2023662,800 shares $530,240.00 +5.0%N/A9.6 $0.80 6/15/2023631,000 shares $542,218.30 -0.1%N/A8.7 $0.86 5/31/2023631,800 shares $574,938.00 -1.2%N/A7.9 $0.91 5/15/2023639,600 shares $562,911.96 -12.4%N/A8 $0.88 4/30/2023730,500 shares $818,160.00 -20.0%N/A8.6 $1.12 4/15/2023913,300 shares $958,965.00 +0.8%N/A9.5 $1.05 3/31/2023906,500 shares $826,818.65 +10.9%N/A4.9 $0.91 3/15/2023817,300 shares $980,760.00 +19.3%N/A1.7 $1.20 2/28/2023685,300 shares $979,979.00 +6.3%N/A1.4 $1.43 2/15/2023644,500 shares $928,080.00 -17.6%N/A1.3 $1.44 1/31/2023781,700 shares $1.17 million +16.7%N/A1.6 $1.50 1/15/2023669,600 shares $1.69 million -17.8%N/A1.4 $2.52 12/30/2022815,000 shares $1.76 million +111.0%N/A2.1 $2.16 12/15/2022386,300 shares $370,732.11 +4.4%3.2%0.9 $0.96 11/30/2022369,900 shares $341,121.78 +4.3%3.9%1.9 $0.92 11/15/2022354,800 shares $325,316.12 +6.2%3.7%1.8 $0.92 10/31/2022334,000 shares $344,020.00 +10.5%3.5%1.7 $1.03 10/15/2022302,300 shares $292,535.71 +484.7%3.0%1.5 $0.97 9/30/202251,700 shares $47,631.21 -38.7%0.5%0.3 $0.92 9/15/202284,300 shares $148,368.00 -11.9%0.8%1.2 $1.76Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. EDSA Short Interest - Frequently Asked Questions What is Edesa Biotech's current short interest? Short interest is the volume of Edesa Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 16,100 shares of EDSA short. 0.69% of Edesa Biotech's shares are currently sold short. Learn More on Edesa Biotech's current short interest. What is a good short interest ratio for Edesa Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDSA shares currently have a short interest ratio of 2.0. Learn More on Edesa Biotech's short interest ratio. What is a good short interest percentage for Edesa Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of Edesa Biotech's floating shares are currently sold short. Is Edesa Biotech's short interest increasing or decreasing? Edesa Biotech saw a increase in short interest in April. As of April 30th, there was short interest totaling 16,100 shares, an increase of 5.9% from the previous total of 15,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edesa Biotech's float size? Edesa Biotech currently has issued a total of 3,220,000 shares. Some of Edesa Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edesa Biotech currently has a public float of 2,330,000 shares. How does Edesa Biotech's short interest compare to its competitors? 0.69% of Edesa Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Edesa Biotech: FSD Pharma Inc. (1.00%), Pieris Pharmaceuticals, Inc. (1.12%), RedHill Biopharma Ltd. (2.38%), Tonix Pharmaceuticals Holding Corp. (1.89%), Purple Biotech Ltd (1.18%), NeuroSense Therapeutics Ltd. (0.16%), Kiora Pharmaceuticals, Inc. (0.56%), Eterna Therapeutics Inc. (1.15%), Imunon, Inc. (3.95%), Vincerx Pharma, Inc. (5.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Edesa Biotech stock? Short selling EDSA is an investing strategy that aims to generate trading profit from Edesa Biotech as its price is falling. EDSA shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edesa Biotech? A short squeeze for Edesa Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EDSA, which in turn drives the price of the stock up even further. How often is Edesa Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDSA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: FSD Pharma Short Interest Data Pieris Pharmaceuticals Short Interest Data RedHill Biopharma Short Interest Data Tonix Pharmaceuticals Short Interest Data Purple Biotech Short Interest Data NeuroSense Therapeutics Short Interest Data Kiora Pharmaceuticals Short Interest Data Eterna Therapeutics Short Interest Data Imunon Short Interest Data Vincerx Pharma Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDSA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trendsis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media